Explore / Clinical trial
Clinical trial

Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial

Definium Therapeutics US, Inc.CompletedPhase 2Started Dec 17, 202153 enrolledNetherlands, SwitzerlandNCT05200936

Abstract

This study measures the safety and efficacy of repeated low dose MM120 as treatment for ADHD in adults: a multi-center, randomized, double-blind, placebo-controlled

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

LSD

Keywords

ADHDAttention Deficit Disorder
View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

This study's objects

Directly linked records, matched by DOI, trial reference, or registry, not just topic.

Publications from this trial

ArticleLSD

Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.

Mueller L, Santos de Jesus J, Schmid Y +9

Europe PMC2025
ArticleLSD

Effects of repeated low-dose LSD on neuropsychological functioning in adults with ADHD: a randomized placebo-controlled study.

Haijen-Bongers ECHM, Hurks PPM, Schepers J +6

Europe PMC2026

Related research

ArticlePsilocybin

MFCC-DFT mapping of ligand recognition at the 5-HT<sub>2A</sub> receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.

Junior WSC, Bezerra KS, Matias EGC +2

Europe PMC2026
ArticleLSD

LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.

Timmermann C, Spriggs MJ, Kaelen M +5

Europe PMC2018
ArticleLSD

Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.

Schindler EA, Harvey JA, Aloyo VJ

Europe PMC2013